Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05135949

Strength After Elbow Fractures in the Elderly

Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.

Recruiting

Interested in participating?

Request Info

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Columbian Hospital

New Westminster, British Columbia, V3L 3W7, Canada

Location status: Recruiting

Location contact

Bertrand Perey

SUB_INVESTIGATOR

Darius Viskontas

SUB_INVESTIGATOR

Dory Boyer

SUB_INVESTIGATOR

Farhad Moola

PRINCIPAL_INVESTIGATOR

Kelly Apostle

SUB_INVESTIGATOR

Kyrsten Butterfield

CONTACT

[email protected]

604-553-3247

Trevor Stone

SUB_INVESTIGATOR

About this study

Elderly patients with an olecranon fracture will receive appropriate treatment as determined by the treating surgeon. Patients will then be assessed at 6 weeks, 6 months and 12 months post treatment. Assessments include, range of motion, patient reported outcomes and a strength test.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥65 years of age
  • Mayo type II olecranon fracture
  • Ambulatory (with or without the use of walking aides)

Exclusion criteria

  • Additional injuries to the affected arm or contralateral arm
  • Associated nerve injury
  • Dementia or cognitive impairment that inhibits the collection of outcome measures
  • Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.)
  • Injury or previous deficit to the contralateral arm
  • Currently enrolled in any other research study involving drugs or medical devices
  • Open fractures
  • Inability to provide informed consent

Treatment and study plan

Patient reported outcomes

Other

Satisfaction, Disabilities of the Shoulder, Arm and Hand

Strength Test

Other

Handheld dynamometer to measure tricep extension

Primary outcomes

  1. Extension Strength

    Time frame: 12 Months

    Patients will push down on their distal forearm through a hand held dynamometer, to measure tricep extension strength

Secondary outcomes

  1. Arc of Motion

    Time frame: 12 months

    Elbow extension and elbow flexion measured with a goniometer

  2. Mayo Elbow Performance Index

    Time frame: 12 Months

    An instrument used to test the limitations, caused by pathology, of the elbow during activities of daily living. Higher scores indicate a better outcome.

  3. Disabilities of the Arm, Shoulder, and Hand

    Time frame: 12 Months

    A 30 Item questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores will indicated better outcomes.Lower scores will indicate better outcomes.

  4. Satisfaction Score

    Time frame: 6 weeks, 6 months and 12 months

    Soccer out of 10, higher the score the better the outcome

Study contacts

Contact information is provided by the study sponsor or research team.

Kyrsten Butterfield, BSc

CONTACT

[email protected]

604-553-3247

Sponsors and collaborators

Lead sponsor

Fraser Orthopaedic Research Society

Network

Registry information

Official study title

Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat

Acronym: STAND-UP

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Nov 26, 2021
Registry last updated
Feb 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.